About turoctocog alfa pegol
Extended half-life factor VIII replacement
Used for
- Prevention and treatment of bleeding in haemophilia A
- Bleeding control during surgery in haemophilia A
Usual adult dose
Dose is individualized by weight, bleed severity, and treatment goal; commonly 50 IU/kg every four days for prevention.
Usual dose in children
Individualized by weight and treatment goal; commonly 60 IU/kg twice weekly for children under 12.
Common side effects
- Injection-site reactions
- Rash or itching
- Headache
- Development of factor VIII inhibitors
Important warnings
- Severe allergic reactions can occur.
- Factor VIII inhibitors may reduce or prevent treatment response.
- Not for von Willebrand disease or haemophilia B.
- Dose and monitoring require specialist supervision.
Pregnancy
Limited human data; use only when clearly needed and under specialist supervision.
Breastfeeding
Unknown whether it passes into breast milk; use requires weighing potential benefits and risks.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.